Font Size: A A A

Nevada Lung Cancer Screening Toolkit

11 November, 2023

This toolkit is designed to assist health systems in building, maintaining, and increasing patient uptake of a lung cancer screening program using low dose computed tomography (LDCT) as recommended by the United States Preventive Services Task Force (USPSTF).

Content contained in this toolkit is the culmination of published and publicly available information on lung cancer screening programs as curated by the Nevada Lung Cancer Collaborative. Additionally, experiences from real-world lung cancer screening implementation experts and researchers have been incorporated where possible.  Attachments include promotional brochures, clinic resources, billing resources, and sample follow-up letters.

A LDCT lung screening program is a comprehensive effort necessitating the collaboration of the full medical team. This toolkit was designed for a variety of health care professionals including, but not limited to:

  • Practice planners and administrators in primary care and community health settings.
  • Practice planners and administrators at radiology and imaging centers.
  • Medical billing specialists.
  • Physicians, non-physician providers, and auxiliary personnel.

Lung cancer screening champions.

You May Also Like

Radon Test Kit
Radon is a hidden lung cancer risk. Testing your home is easy and free right now.
01.07.2026
  • lung cancer
  • prevention
  • radon
When people think about lung cancer risk, smoking is often the first thing that comes to mind.
a display of salami
Ultra-processed foods and lung cancer: What a large U.S. study means for prevention
01.05.2026
  • lung cancer
  • nutrition
Lung cancer remains the leading cause of cancer death worldwide, and while smoking is the dominant risk factor, it is not the only one shaping who
three physicians review information on a clipboard, graphics representing AI and data are overlaid on the image
Harnessing AI to catch lung cancer earlier
12.23.2025
  • lung cancer
Lung cancer remains the leading cause of cancer deaths, in part because early-stage disease is often missed until symptoms appear.